Greyt Ventures LLC 13D and 13G filings for Organicell Regenerative Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-16 4:08 pm Purchase | 2022-08-19 | 13D | Organicell Regenerative Medicine, Inc. BPSR | Greyt Ventures LLC | 200,000,000 12.300% | 200,000,000 (New Position) | Filing |